Sanara MedTech Inc. (SMTI)

NASDAQ: SMTI · Real-Time Price · USD
33.77
-1.51 (-4.28%)
Sep 12, 2025, 4:00 PM EDT - Market closed
-4.28%
Market Cap300.63M
Revenue (ttm)97.24M
Net Income (ttm)-9.94M
Shares Out 8.90M
EPS (ttm)-1.16
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume29,571
Open35.03
Previous Close35.28
Day's Range33.00 - 35.03
52-Week Range23.53 - 39.08
Beta1.19
AnalystsStrong Buy
Price Target50.00 (+48.06%)
Earnings DateNov 11, 2025

About SMTI

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a fre... [Read more]

Sector Healthcare
Founded 1982
Employees 141
Stock Exchange NASDAQ
Ticker Symbol SMTI
Full Company Profile

Financial Performance

In 2024, Sanara MedTech's revenue was $86.67 million, an increase of 33.36% compared to the previous year's $64.99 million. Losses were -$9.66 million, 124.6% more than in 2023.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for SMTI stock is "Strong Buy." The 12-month stock price target is $50.0, which is an increase of 48.06% from the latest price.

Price Target
$50.0
(48.06% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Sanara MedTech: Growth Remains Strong As Debt Concerns Recede

SMTI's Surgical segment revenue grew 28% year-over-year in Q1 to $25.8 million. Surgical segment adjusted EBITDA was $4.7 million, while THP correspondingly posted a loss of $2.1 million. Management i...

10 days ago - Seeking Alpha

Sanara MedTech Inc. Announces Chief Executive Officer Transition

Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Compan...

12 days ago - GlobeNewsWire

Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025

FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializ...

18 days ago - GlobeNewsWire

Sanara MedTech Inc. (SMTI) Q2 2025 Earnings Call Transcript

Sanara MedTech Inc. (NASDAQ:SMTI) Q2 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants Elizabeth B. Taylor - Chief Financial Officer Ronald T.

4 weeks ago - Seeking Alpha

Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)

Net Revenue Increased  28% Year-Over-Year in Q2; Increased 27% Year-Over-Year in First Six Months of 2025 Announces Process to Evaluate Strategic Alternatives for its Tissue Health Plus, LLC Subsidiar...

4 weeks ago - GlobeNewsWire

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformativ...

2 months ago - GlobeNewsWire

Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program

Pilot program designed to provide real-world evidence in the use of Tissue Health Plus' technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Compan...

2 months ago - GlobeNewsWire

Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb

Sanara MedTech's surgical revenue grew 26% year-over-year in Q1, with a gross margin of 92%. Surgical adjusted EBITDA was $2.7 million in Q1, while THP correspondingly posted a loss of $2 million. Hig...

3 months ago - Seeking Alpha

Sanara MedTech Inc. (SMTI) Q1 2025 Earnings Call Transcript

Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman, Chief Executive Officer Seth Yon - President, Chief Com...

4 months ago - Seeking Alpha

Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)

Q1 Net Revenue Increased 26% Year-Over-Year FORT WORTH, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology com...

4 months ago - GlobeNewsWire

Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformati...

5 months ago - GlobeNewsWire

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commerciali...

5 months ago - GlobeNewsWire

Sanara MedTech Inc. (SMTI) Q4 2024 Earnings Call Transcript

Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2024 Earnings Conference Call March 25, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman and Chief Executive Officer Seth Yon - President, Comm...

6 months ago - Seeking Alpha

Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

Q4 Net Revenue Increased 49% Year-Over-Year; 2024 Net Revenue Increased 33% Year-Over-Year FORT WORTH, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” ...

6 months ago - GlobeNewsWire

Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

FORT WORTH, TX, March 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformati...

6 months ago - GlobeNewsWire

Sanara MedTech: A Promising Growth Story At An Attractive Valuation

Shares have risen nearly 15% since the company posted preliminary Q4 results, which showed revenue up by 45-48% year over year. While growth was boosted by one-off demand for its BIASURGE product, und...

8 months ago - Seeking Alpha

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and d...

8 months ago - GlobeNewsWire

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

OsStic ® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually ( 1) ; arrangement leverages Sanara's existing call points and c...

8 months ago - GlobeNewsWire

Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

Elizabeth Taylor Appointed Chief Financial Officer;  Michael McNeil Appointed Chief Accounting Officer and Chief Administrative Officer

8 months ago - GlobeNewsWire

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024

Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year

8 months ago - GlobeNewsWire

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

FORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technolog...

10 months ago - GlobeNewsWire

Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript

Sanara MedTech Inc. (NASDAQ:SMTI) Q3 2024 Earnings Conference Call November 13, 2024 9:00 AM ET Company Participants Ronald Nixon - Executive Chairman and CEO Seth Yon - President of Commercial Micha...

10 months ago - Seeking Alpha

Sanara MedTech Inc. Reports Third Quarter 2024 Results

FORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technolog...

10 months ago - GlobeNewsWire

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

FORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technolog...

11 months ago - GlobeNewsWire

Sanara MedTech Inc. Announces Changes to Its Board of Directors

FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focuse...

1 year ago - GlobeNewsWire